Author
MARKLUND, MATTI - University Of New South Wales | |
WU, JASON - University Of New South Wales | |
IMAMURA, FUMIAKI - University Of Cambridge | |
DEL GOBBO, LIANA - Stanford University | |
FRETTS, AMANDA - University Of Washington | |
DE GOEDE, JANETTE - University Of Wageningen | |
SHI, PEILIN - Tufts University | |
TINTLE, NATHAN - Dordt College | |
WENNBERG, MARIA - University Of Umea | |
ASLIBEKYAN, STELLA - University Of Alabama | |
CHEN, TZU-AN - Baylor University | |
DE OLIVEIRA OTTO, MARCIA - University Of Texas | |
HIRAKAWA, YOICHIRO - Kyushu University | |
ERIKSEN, HELLE - Aalborg University | |
KROGER, JANINE - German Institute Of Human Nutrition | |
LAGUZZI, FEDERICA - Karolinska Institute | |
LANKINEN, MARIA - University Of Eastern Finland | |
MURPHY, RACHEL - University Of British Columbia | |
PREM, KIESHA - National University Of Singapore | |
SAMIERI, CECILIA - University Of Bordeaux | |
VIRTANEN, JYRKI - University Of Eastern Finland | |
WOOD, ALEXIS - Children'S Nutrition Research Center (CNRC) | |
WONG, KERRY - University Of Melbourne | |
YANG, WEI-SIN - National Taiwan University | |
ZHOU, XIA - University Of Minnesota | |
BAYLIN, ANA - University Of Michigan | |
BOER, JOLANDA - National Institute For Public Health And The Environment (RIVM) | |
BROUWER, INGEBORG - Vrije University | |
CAMPOS, HANNIA - Harvard University | |
CHAVES, PAULO - Florida International University | |
CHIEN, KUO-LIONG - National Taiwan University | |
DE FAIRE, ULF - Karolinska Institute | |
DJOUSSE, LUC - Brigham & Women'S Hospital | |
EIRIKSDOTTIR, GUDNY - Icelandic Heart Association | |
EL-ABBADI, NAGLAA - Jean Mayer Human Nutrition Research Center On Aging At Tufts University | |
FOROUHI, NITA - University Of Cambridge | |
GAZIANO, J - Brigham & Women'S Hospital | |
GELEIJNSE, JOHANNA - University Of Wageningen | |
GIGANTE, BRUNA - Karolinska Institute | |
GILES, GRAHAM - University Of Melbourne | |
GUALLAR, ELISEO - Johns Hopkins University | |
GUDNASON, VILMUNDUR - University Of Iceland | |
HARRIS, TAMARA - National Institute On Aging (NIA, NIH) | |
HARRIS, WILLIAM - University Of South Dakota | |
HELMER, CATHERINE - University Of Bordeaux | |
HELLENIUS, MAI-LIS - Karolinska Institute | |
HODGE, ALLISON - University Of Melbourne | |
HU, FRANK - Harvard University | |
JACQUES, PAUL - Jean Mayer Human Nutrition Research Center On Aging At Tufts University | |
JANSSON, JAN-HAKAN - University Of Umea | |
KALSBEEK, ANYA - Dordt College | |
KHAW, KAY-TEE - University Of Cambridge | |
KOH, WOON-PUAY - National University Of Singapore | |
LAAKSO, MARKKU - University Of Eastern Finland | |
LEANDER, KARIN - Karolinska Institute | |
LIN, HUNG-JU - National Taiwan University | |
LIND, LARS - Uppsala University | |
LUBEN, ROBERT - University Of Cambridge | |
LUO, JUHUA - Indiana University | |
MCKNIGHT, BARBARA - University Of Washington | |
MURSU, JAAKKO - University Of Eastern Finland | |
NINOMIYA, TOSHIHARU - Kyushu University | |
OVERVAD, KIM - Aarhus University | |
PSATY, BRUCE - University Of Washington | |
RIMM, ERIC - Harvard University | |
SCHULZE, MATTHIAS - German Institute Of Human Nutrition | |
SISCOVICK, DAVID - New York Academy Of Medicine | |
SKJELBO NIELSEN, MICHAEL - Aalborg University | |
SMITH, ALBERT - University Of Iceland | |
STEFFEN, BRIAN - University Of Minnesota | |
STEFFEN, LYN - University Of Minnesota | |
SUN, QI - Harvard University | |
SUNDSTROM, JOHAN - Uppsala University | |
TSAI, MICHAEL - University Of Minnesota | |
TUNSTALL-PEDOE, HUGH - University Of Dundee | |
UUSITUPA, MATTI - University Of Eastern Finland | |
VAN DAM, ROB - National University Of Singapore | |
VEENSTRA, JENNA - Dordt College | |
VERSCHUREN, W.M. - National Institute For Public Health And The Environment (RIVM) | |
WAREHAM, NICK - University Of Cambridge | |
WILLETT, WALTER - Harvard University | |
WOODWARD, MARK - University Of New South Wales | |
YUAN, JIAN-MIN - University Of Pittsburgh | |
MICHA, RENATA - Tufts University | |
LEMAITRE, ROZENN - University Of Washington | |
MOZAFFARIAN, DARIUSH - Tufts University | |
RISERUS, ULF - Uppsala University |
Submitted to: Circulation
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 2/7/2019 Publication Date: 5/21/2019 Citation: Marklund, M., Wu, J.H., Imamura, F., Del Gobbo, L.C., Fretts, A., De Goede, J., Shi, P., Tintle, N., Wennberg, M., Aslibekyan, S., Chen, T., De Oliveira Otto, M.C., Hirakawa, Y., Eriksen, H.H., Kroger, J., Laguzzi, F., Lankinen, M., Murphy, R.A., Prem, K., Samieri, C., Virtanen, J., Wood, A.C., Wong, K., Yang, W., Zhou, X., Baylin, A., Boer, J.M., Brouwer, I.A., Campos, H., Chaves, P.H., Chien, K., De Faire, U., Djousse, L., Eiriksdottir, G., El-Abbadi, N., Forouhi, N.G., Gaziano, J., Geleijnse, J.M., Gigante, B., Giles, G., Guallar, E., Gudnason, V., Harris, T., Harris, W.S., Helmer, C., Hellenius, M., Hodge, A., Hu, F.B., Jacques, P.F., Jansson, J., Kalsbeek, A., Khaw, K., Koh, W., Laakso, M., Leander, K., Lin, H., Lind, L., Luben, R., Luo, J., Mcknight, B., Mursu, J., Ninomiya, T., Overvad, K., Psaty, B.M., Rimm, E., Schulze, M.B., Siscovick, D., Skjelbo Nielsen, M., Smith, A.V., Steffen, B.T., Steffen, L., Sun, Q., Sundstrom, J., Tsai, M.Y., Tunstall-Pedoe, H., Uusitupa, M.I., Van Dam, R.M., Veenstra, J., Verschuren, W.M., Wareham, N., Willett, W., Woodward, M., Yuan, J., Micha, R., Lemaitre, R.N., Mozaffarian, D., Riserus, U. 2019. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: an individual-level pooled analysis of 30 cohort studies. Circulation. 139(21):2422-2436. https://doi.org/10.1161/CIRCULATIONAHA.118.038908. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.038908 Interpretive Summary: Controversy exists around the effect of consuming omega-6 polyunsaturated fatty acids, a type of polyunsaturated fatty acid found in vegetable oils, seeds and nuts, on cardiovascular disease risk. As such, our study aimed to examine the association between blood levels of two types of omega-6 fatty acids, linoleic acid (LA) and arachidonic acid (AA), and new cases of CVD. To do this, we conducted a meta-analysis, which is a study that combines data from many individual studies on the topic. Our meta-analysis includes results from 30 studies conducted in 13 different countries and is the largest meta-analysis to examine the link between LA, AA, and CVD. The results showed that a higher blood level of LA was associated with lower risk of total CVD, ischemic stroke, and death from cardiovascular disease. AA was not associated with cardiovascular risk. These findings are novel in that they suggest that omega-6 fatty acids, specifically LA, may be beneficial for preventing CVD. This study does not support previous beliefs that omega-6 fatty acids may be harmful to CVD risk, and the results can be used to help inform global dietary recommendations about omega-6 fatty acid consumption. Technical Abstract: Background: Global dietary recommendations for and cardiovascular effects of linoleic acid, the major dietary omega-6 fatty acid, and its major metabolite, arachidonic acid, remain controversial. To address this uncertainty and inform international recommendations, we evaluated how in vivo circulating and tissue levels of linoleic acid (LA) and arachidonic acid (AA) relate to incident cardiovascular disease (CVD) across multiple international studies. Methods: We performed harmonized, de novo, individual-level analyses in a global consortium of 30 prospective observational studies from 13 countries. Multivariable-adjusted associations of circulating and adipose tissue LA and AA biomarkers with incident total CVD and subtypes (coronary heart disease, ischemic stroke, cardiovascular mortality) were investigated according to a prespecified analytic plan. Levels of LA and AA, measured as the percentage of total fatty acids, were evaluated linearly according to their interquintile range (ie, the range between the midpoint of the first and fifth quintiles), and categorically by quintiles. Study-specific results were pooled using inverse-variance-weighted meta-analysis. Heterogeneity was explored by age, sex, race, diabetes mellitus, statin use, aspirin use, omega-3 levels, and fatty acid desaturase 1 genotype (when available). Results: In 30 prospective studies with medians of follow-up ranging 2.5 to 31.9 years, 15 198 incident cardiovascular events occurred among 68 659 participants. Higher levels of LA were significantly associated with lower risks of total CVD, cardiovascular mortality, and ischemic stroke, with hazard ratios per interquintile range of 0.93 (95% CI, 0.88-0.99), 0.78 (0.70-0.85), and 0.88 (0.79-0.98), respectively, and nonsignificantly with lower coronary heart disease risk (0.94; 0.88-1.00). Relationships were similar for LA evaluated across quintiles. AA levels were not associated with higher risk of cardiovascular outcomes; in a comparison of extreme quintiles, higher levels were associated with lower risk of total CVD (0.92; 0.86-0.99). No consistent heterogeneity by population subgroups was identified in the observed relationships. Conclusions: In pooled global analyses, higher in vivo circulating and tissue levels of LA and possibly AA were associated with lower risk of major cardiovascular events. These results support a favorable role for LA in CVD prevention. |